|   encounter_num | encounter_date   | encounter_summary                                                                                                                                           |
|----------------:|:-----------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------|
|               1 | 2025-06-01       | Pre-op H&P for DDKT; X-linked Alport syndrome; ABO O+, cPRA 0%; T/B-cell flow crossmatch negative                                                           |
|               2 | 2025-06-01       | Operative + immediate post-op: DDKT to left iliac fossa; CIT 18 h; WIT 32 min; immediate urine output                                                       |
|               3 | 2025-06-02       | Inpatient POD#1: creatinine falling 6.8→2.9 mg/dL; tacrolimus initiation; MMF; steroid taper; CMV/PCP prophylaxis started; baseline CMV/EBV/BK PCR negative |
|               4 | 2025-06-04       | Inpatient POD#3: tac trough 4.3 ng/mL (goal 7–9) → dose increased; renal ultrasound normal RI 0.65; plan discharge tomorrow                                 |
|               5 | 2025-06-05       | Discharge summary: uncomplicated course; Foley out; ureteral stent in place; home with tacrolimus/MMF/prednisone; valganciclovir and TMP-SMX                |
|               6 | 2025-06-10       | Outpatient week 1: creatinine 1.2 mg/dL; tac trough 5.8 → dose increased; BP controlled; DSA screen negative; CMV D+/R-, EBV D+/R-                          |
|               7 | 2025-06-17       | Outpatient week 2: creatinine 1.1; tac trough 7.2 (in range); BK PCR not detected; adherence reviewed with family                                           |
|               8 | 2025-07-01       | Outpatient month 1: stent removed without complication; ultrasound normal; DSA negative; mild MMF GI upset → divided dosing                                 |
|               9 | 2025-07-29       | Outpatient month 2: creatinine 1.0; tremor with tac trough 11.5 → dose reduced; BK PCR 800 copies/mL → monitor                                              |
|              10 | 2025-08-26       | Outpatient month 3: creatinine 1.0; BK PCR 3,200 copies/mL → reduce MMF by 25%; DSA negative; no proteinuria                                                |
|              11 | 2025-09-23       | Outpatient month 4: BK PCR <500 (not detected); creatinine 1.0; EBV PCR negative; influenza vaccine given; continue valganciclovir                          |